Header Logo

Connection

CULLEN TANIGUCHI to Biomarkers

Back to Details
This is a "connection" page, showing publications CULLEN TANIGUCHI has written about Biomarkers.
CULLEN TANIGUCHI
Connection Strength
0.023
Biomarkers
  1. Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation. Int J Radiat Oncol Biol Phys. 2022 11 01; 114(3):444-453.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.